Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematological Malignancy”

206 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 206 results

Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Early research (Phase 1)Not Yet RecruitingNCT07044544
What this trial is testing

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

Who this might be right for
Myeloid MalignancyHematologic MalignancyAcute Myeloid Leukemia+1 more
University of Alabama at Birmingham 20
Not applicableLooking for participantsNCT06253338
What this trial is testing

Optimization of Radiation Protection Through Genomic Analyses

Who this might be right for
DNACancerRadiation
University Hospital, Essen 30
Not applicableLooking for participantsNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Testing effectiveness (Phase 2)Study completedNCT01200485
What this trial is testing

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT03680092
What this trial is testing

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Who this might be right for
GVHDHematologic Neoplasms
Dimitrios Tzachanis, MD PhD 43
Testing effectiveness (Phase 2)Study completedNCT01315132
What this trial is testing

Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+2 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 47
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT03670966
What this trial is testing

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia in Remission+9 more
Fred Hutchinson Cancer Center 30
Early research (Phase 1)Ended earlyNCT00963495
What this trial is testing

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more
University Health Network, Toronto 11
Large-scale testing (Phase 3)Study completedNCT00750737
What this trial is testing

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

Who this might be right for
Invasive Fungal InfectionsHematologic Malignancies
M.D. Anderson Cancer Center 46
Post-approval studies (Phase 4)Study completedNCT02149329
What this trial is testing

Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO

Who this might be right for
Febrile NeutropeniaHematological Malignancy
Amsterdam UMC, location VUmc 276
Testing effectiveness (Phase 2)Study completedNCT00002831
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT05908409
What this trial is testing

IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Multiple Myeloma (MM)Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedDouble Hit Lymphoma+3 more
IDP Discovery Pharma S.L. 37
Large-scale testing (Phase 3)Looking for participantsNCT04116502
What this trial is testing

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

Who this might be right for
Polycythemia Vera
University of Birmingham 586
Testing effectiveness (Phase 2)Study completedNCT01860170
What this trial is testing

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Hematological Malignancy
Corewell Health West 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04103879
What this trial is testing

US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia

Who this might be right for
High Risk Hematological MalignancyCord Blood Transplant
ExCellThera inc. 30
Large-scale testing (Phase 3)Looking for participantsNCT05198960
What this trial is testing

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaPrefibrotic/Early Primary Myelofibrosis+2 more
University Hospital, Brest 1,308
Early research (Phase 1)WithdrawnNCT02487459
What this trial is testing

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Bellicum Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Load More Results